Blocknomi
Key Highlights Shares of Travere Therapeutics (TVTX) climbed 44% following FDA clearance of FILSPARI for treating FSGS FILSPARI represents the inaugural FDA-sanctioned therapy for focal segmental glomerulosclerosis The treatment is…
Related articles
-
Hungary Election Political Shake-Up Could Reopen Crypto Policy and Regulation Debate
Cryptonews Published 13.04.2026 12:03
-
Aave DAO Approves $25M Funding Package for Aave Labs Under New Governance Model
Blocknomi Published 13.04.2026 07:20
-
Aave Is Trading Like 2022 Again: Danger Zone Or Entry Point?
NewsBTC Published 18.04.2026 00:00
-
Bitcoin Price Surges on Biggest Accumulation Wave Since 2013
CryptoNewsZ Published 16.04.2026 20:51
-
Nokia (NOK) Stock Surges Following Bank of America’s Bullish Upgrade on AI Infrastructure Play
Blocknomi Published 13.04.2026 17:04
-
Bears Are Fully In Control Of Bitcoin And It Will Crash Below $60,000, Here’s Why
NewsBTC Published 22.04.2026 20:00
-
FBI says crypto-related fraud losses hit record $11.4 billion in 2025, with seniors bearing the brunt
The Block Published 12.04.2026 20:13
-
Circle rolls out USDC Bridge for native cross-chain stablecoin transfers
The Block Published 17.04.2026 15:43